Litcius/Paper detail

Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets

Vancha Harish, Effi Haque, Magdalena Śmiech, Hiroaki Taniguchi, Sarah Jamieson, Devesh Tewari, Anupam Bishayee

2021International Journal of Molecular Sciences82 citationsDOIOpen Access PDF

Abstract

L. (Hop plant). XH is an important ingredient in beer and is considered a significant bioactive agent due to its diverse medicinal applications, which include anti-inflammatory, antimicrobial, antioxidant, immunomodulatory, antiviral, antifungal, antigenotoxic, antiangiogenic, and antimalarial effects as well as strong anticancer activity towards various types of cancer cells. XH acts as a wide ranging chemopreventive and anticancer agent, and its isomer, 8-prenylnaringenin, is a phytoestrogen with strong estrogenic activity. The present review focuses on the bioactivity of XH on various types of cancers and its pharmacokinetics. In this paper, we first highlight, in brief, the history and use of hops and then the chemistry and structure-activity relationship of XH. Lastly, we focus on its prominent effects and mechanisms of action on various cancers and its possible use in cancer prevention and treatment. Considering the limited number of available reviews on this subject, our goal is to provide a complete and detailed understanding of the anticancer effects of XH against different cancers.

Topics & Concepts

XanthohumolHumulus lupulusAntifungalChemistryAntimicrobialPharmacologyCancerFlavonoidPharmacokineticsComputational biologyTraditional medicineBiochemistryAntioxidantBiologyMedicinePepperMicrobiologyEcologyKey (lock)GeneticsFood scienceOrganic chemistryHops Chemistry and ApplicationsPowdery Mildew Fungal DiseasesHorticultural and Viticultural Research
Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets | Litcius